Abstract Details

Title Risk of ischemic stroke recurrence in patients with atrial fibrillation diagnosed after stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P6 - (-)

Poster/Presentation
Number 245

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Luciano A. Sposato, MD (London Health Sciences Centre) PRESENTER	Dr. Sposato has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gore.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Sebastian Fridman, MD (LHSC Western University)	Dr. Fridman has nothing to disclose.
	No disclosure on file
Gustavo Saposnik, MD (Director, Clinical Outcomes & Decision Neuroscience Research Centre)	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.

��ɫ����